Amrubicin
- Generic Name
- Amrubicin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H25NO9
- CAS Number
- 110267-81-7
- Unique Ingredient Identifier
- 93N13LB4Z2
- Background
Amrubicin is a third-generation synthetic anthracycline currently in development for the treatment of small cell lung cancer. Pharmion licensed the rights to Amrubicin in November 2006. In 2002, Amrubicin was approved and launched for sale in Japan based on Phase 2 efficacy data in both SCLC and NSCLC. Since January 2005, Amrubicin has been marketed by Nippo...
- Indication
Investigated for use/treatment in lung cancer .
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath